EMA: Waiving MD study [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2020-09-09 17:43 (180 d 06:41 ago) – Posting: # 21913
Views: 1,987

Hi Helmut,

» at the end an [image] script to play with.
»
» For any elimination half life of > 7 hours and an intended dosing interval of 24 hours it will be impossible to get the MD study waived. Red are formulations with flip-flop PK (kakel).

Could you please kindly add more explanation.

Cheers,
Osama

Complete thread:

Activity
 Admin contact
21,372 posts in 4,463 threads, 1,495 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 23:24 CET (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5